RESPONSIBLE CARE
OUR COMMITMENT TO DEEPARKNTRIT

DEEPAK NITRITE

DNL/140/NSE/1658/2026
15th May, 2026

Listing Department
National Stock Exchange of India Limited,
Exchange Plaza
Bandra Kurla Complex
Bandra (E)
MUMBAI - 400 051

Dear Sir,

Stock Symbol: DEEPAKNTR

Sub: Intimation about Changes in Directors of the Company

Pursuant to the requirements of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) this is to inform you that the Board of Directors of Deepak Nitrite Limited (“Company”) at its meeting held today i.e. 15th May, 2026, has approved -

1) Re-appointment of Shri Girish Satarkar (DIN: 00340116) as a Whole-time Director designated as Executive Director of the Company for a period of 3 (three) years with effect from 4th August, 2026, subject to approval of Shareholders of the Company at the ensuing Annual General Meeting of the Company.

2) Recommending to the shareholders for their approval at the ensuing Annual General Meeting of the Company, appointment of Shri Anant Pande (DIN: 08186854) as a Director liable to retire by rotation in place of Shri Ajay C. Mehta (DIN: 00028405), who retires at the ensuing Annual General Meeting of the Company and has not offered himself for the re-appointment.

3) Appointment of Shri Anant Pande (DIN: 08186854) as a Whole-time Director designated as the Executive Director & Chief Manufacturing Officer (CMO) of the Company for a period of 3 (three) years with effect from 5th August, 2026, subject to approval of shareholders of the Company at the ensuing Annual General Meeting of the Company.

The Board Meeting commenced at 2:10 P.M. and concluded at 4:30 P.M.

DEEPAK NITRITE LIMITED
CIN: L24110GJ1970PLC001735
Registered & Corporate Office:
2nd Floor, Fermenter House, Alembic City, Alembic Avenue Road, Vadodara – 390 003, Gujarat, India.
Tel: +91 265 276 5200/276 5500
Investor Relations Contact: [email protected]
www.godeepak.com

RESPONSIBLE CARE
OUR OWNERSHIP TO INTERNATIONAL

DEEPAK NITRITE

Additional details as required under Regulation 30 of Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 are enclosed as Annexure-I.

Kindly take the same on your record.

Thanking you,

Yours faithfully,

For DEEPAK NITRITE LIMITED

Arvind Digitally signed
by Arvind Bajpai
Date: 2026.05.15
Bajpai 18:37:51 +05'00'
ARVIND BAJPAI
Company Secretary

Encl.: as above

Annexure-I

Additional Details as required under Regulation 30 and other relevant provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015:

Re-appointment of Shri Girish Satarkar (DIN:00340116) as a Whole-time Director designated as Executive Director of the Company with effect from 4th August, 2026

Name of the Director	Shri Girish Satarkar
Reason for Change	Re-appointment as a Whole-time Director designated as Executive Director of the Company.
Date of Appointment & term of appointment:	With effect from 4th August, 2026, for a period of three (3) years.
Brief profile:	Shri Girish Satarkar, has done B.Sc. (Tech) and M.Sc. (Tech) in Textile Chemistry from The Institute of Chemical Technology, ICT (formerly UDCT) University of Mumbai. He has also done Masters of Marketing Management (MMM) from Welingkar Institute of Management, University of Mumbai.

He has wide & rich experience of over 37 years in the Chemical Industry including 18 years in the leadership position.

He is proficient in business affairs with hands-on experience of managing operations and having a good understanding about risk management and corporate governance. A widely travelled person with exposure to international & domestic marketing and has been involved in market & product development activities since many years. |
| Disclosure of relationship between Director | Not related to any of the Directors or Key Managerial Personnel of the Company. |
| Information as required under Circular No. LIST/ COMP/ 14/ 2018-19 and NSE/ CML/ 2018/ 02 dated June 20, 2018 issued by the BSE and NSE, respectively. | Shri Girish Satarkar is not debarred from holding office of a Director by virtue of any SEBI Order or any other such authority. |

SURITY OF MURPHY

Retirement of Shri Ajay C. Mehta (DIN:00028405), at the ensuing Annual General Meeting

Name of the Director	Shri Ajay C. Mehta
Reason for Change	Shri Ajay C. Mehta is retiring by rotation at the ensuing Annual General Meeting and has not offered himself for the re-appointment.
Date of Cessation	August 5, 2026
Date of Appointment & term of appointment:	NA
Brief profile:	NA
Disclosure of relationship between Director	NA
Information as required under Circular No. LIST/COMP/14/2018-19 and NSE/CML/2018/02 dated June 20, 2018 issued by the BSE and NSE, respectively.	NA

Appointment of Shri Anant Pande (DIN: 08186854) as a Director liable to retire by rotation in place of Shri Ajay C. Mehta (DIN:00028405) and as a Whole-time Director designated as Executive Director & CMO of the Company for a period of 3 (three) consecutive years with effect from 5th August, 2026

Name of the Director	Shri Anant Pande
Reason for Change	Appointment as Executive Director & Chief Manufacturing Officer of the Company.
Date of Appointment & term of appointment:	With effect from 5th August, 2026 for a period of 3 (three) consecutive years.
Liable to retire by rotation.
Brief profile:	Shri Anant Pande, aged 63 years, has done B.E. (Hons.) - Chemical & M.Sc. (Hons.) - Chemistry from Birla Institute of Technology & Science, Pilani, Rajasthan. He has also completed Executive Diploma in Management from Kirloskar Institute of Advanced Management Studies, Harihar, Karnataka, India.

Shri Anant Pande has around 40 years of rich experience in life science chemicals and pharmaceutical companies in developing and implementing growth strategies.

Shri Anant Pande was associated with Dhampur Sugar Mills Limited as the Chief Executive Officer. He was previously associated with Jubilant Life Sciences as Whole time Director & Chief of Operations.

He has held leadership positions in various companies such as Atul Limited (President - Technology & Manufacturing), Jubilant Life Sciences Limited (President - Manufacturing & Projects), Continental Carbon India Limited (Chief Executive - Operations), Indo Greefuel Private Limited (Chief Operating Officer) and also in Aditya Birla Group.

He also co-chairs Manufacturing Excellence Committee of Federation of Indian Chambers of Commerce & Industry (FICCI). |

Disclosure of relationship between Director	Not related to any of the Directors or Key Managerial Personnel of the Company.
Information as required under Circular No. LIST/COMP/14/2018-19 and NSE/CML/2018/02 dated June 20, 2018 issued by the BSE and NSE, respectively.	Shri Anant Pande is not debarred from holding office of a Director by virtue of any SEBI Order or any other such authority.